Literature DB >> 7283418

Properties of Streptomyces fradiae mutants blocked in biosynthesis of the macrolide antibiotic tylosin.

R H Baltz, E T Seno.   

Abstract

We isolated numerous mutants of Streptomyces fradiae blocked in tylosin biosynthesis after N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis. These mutants were classified into nine groups, based upon the tylosin-like compounds produced and upon cofermentation analyses. More than 80% of the mutants isolated produced no tylosin-like compounds, and the majority of these were blocked only in the formation of tylactone. Four classes of mutants blocked in the biosynthesis or addition of tylosin sugars were isolated; tylA mutants were blocked in the formation of all three tylosin sugars, whereas tylB, tylC, and tylD mutants were blocked specifically in the biosynthesis or the addition of mycaminose, mycarose, and 6-deoxy-d-allose, respectively. Two classes of mutants (tylH and tylI) blocked in specific oxidations of tylactone and two classes (tylE and tylF) blocked in specific O-methylations of demethylmacrocin and macrocin were also characterized. Cofermentation and bioconversion studies with these mutants suggested the following relationships: (i) the tylosin sugars are derived from a common intermediate; (ii) tylactone is the first intermediate which can be excreted in appreciable quantities; (iii) the addition of mycaminose to the C-5 hydroxyl group of tylactone must precede oxidations at C-20 and C-23; (iv) oxidation at C-20 normally precedes the attachment of mycarose to the 4' hydroxyl position of mycaminose; and (v) 6-deoxy-d-allose is added to the C-23 hydroxyl position of the lactone and subsequently O-methylated at 2''' and 3''' positions. The O-methylations appear to be the final two steps in tylosin biosynthesis, and the 2''' O-methylation must occur before the 3''' O-methylation can take place. All of the tyl mutants except the tylG mutants produced relatively high levels of tylosin-like intermediates or shunt products. Mutants blocked in specific steps other than 3''' O-methylation, including a mutant blocked in 2''' O-methylation of demethylmacrocin, produced normal levels of macrocin O-methyltransferase. Mutants apparently containing specific tylosin structural gene mutations produced normal levels of aerial mycelia and spores, produced low levels of tylosin aldehyde reductase, and were resistant to high levels of tylosin. However, three atypical tylG mutants produced no tylosin-like compounds, could not cosynthesize tylosin with any other tyl mutant, could not bioconvert tylactone or macrocin to tylosin, and produced no macrocin O-methyltransferase. These three mutants produced elevated levels of tylosin aldehyde reductase. In addition, one was very succeptible to tylosin and did not produce aerial mycelia or spores.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283418      PMCID: PMC181666          DOI: 10.1128/AAC.20.2.214

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Chemical and biological studies on 16-membered macrolide antibiotics.

Authors:  S Omura; A Nakagawa
Journal:  J Antibiot (Tokyo)       Date:  1975-06       Impact factor: 2.649

2.  Localized mutagenesis in Streptomyces coelicolor A3 (2).

Authors:  R Randazzo; G Sciandrello; A Carere; M Bignami; A Velcich; G Sermonti
Journal:  Mutat Res       Date:  1976-09       Impact factor: 2.433

3.  [Metabolic products of microorganisms. 114. Thymidine diphospho-D-glucose oxidoreductase from Streptomyces rimosus].

Authors:  H Matern; G U Brillinger; H Pape
Journal:  Arch Mikrobiol       Date:  1973

4.  [Metabolic products of microorganisms. 113. Biosynthesis of thymidine diphospho mycarose in a cell-free system from Streptomyces rimosus].

Authors:  H Pape; G U Brillinger
Journal:  Arch Mikrobiol       Date:  1973

5.  Microbial conversion of antibiotics. IV. Reduction of maridomycin.

Authors:  K Nakahama; S Igarasi
Journal:  J Antibiot (Tokyo)       Date:  1974-08       Impact factor: 2.649

6.  The structure of tylosin.

Authors:  R B Morin; M Gorman; R L Hamill; P V Demarco
Journal:  Tetrahedron Lett       Date:  1970-11       Impact factor: 2.415

Review 7.  The biochemistry of mutagenesis.

Authors:  J W Drake; R H Baltz
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

8.  Studies on the biosynthesis of basic 16-membered macrolide antibiotics, platenomycins. IV. Biosynthesis of platenomycins.

Authors:  T Furumai; K Takeda; M Suzuki
Journal:  J Antibiot (Tokyo)       Date:  1975-10       Impact factor: 2.649

9.  Maridomycin, a new macrolide antibiotic. VII. Incorporation of labeled precursors into maridomycin and preparation of 14C-labeled 9-propionylmaridomycin.

Authors:  H Ono; S Harada; T Kishi
Journal:  J Antibiot (Tokyo)       Date:  1974-06       Impact factor: 2.649

10.  Mutangenesis by N-methyl-N'-nitro-N-nitrosoguanidine (NTG) in Streptomyces coelicolor.

Authors:  V Delić; D A Hopwood; E J Friend
Journal:  Mutat Res       Date:  1970-02       Impact factor: 2.433

View more
  40 in total

1.  Branched-chain fatty acids produced by mutants of Streptomyces fradiae, putative precursors of the lactone ring of tylosin.

Authors:  M L Huber; J W Paschal; J P Leeds; H A Kirst; J A Wind; F D Miller; J R Turner
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 2.  Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2010-05-14       Impact factor: 3.346

Review 3.  Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2015-09-12       Impact factor: 3.346

Review 4.  Natural product discovery: past, present, and future.

Authors:  Leonard Katz; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01-06       Impact factor: 3.346

5.  Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in biosynthesis of mycinamicin macrolide antibiotics.

Authors:  Yojiro Anzai; Shengying Li; Mani Raj Chaulagain; Kenji Kinoshita; Fumio Kato; John Montgomery; David H Sherman
Journal:  Chem Biol       Date:  2008-09-22

6.  Novel Biotransformations of 7-Ethoxycoumarin by Streptomyces griseus.

Authors:  F S Sariaslani; J P Rosazza
Journal:  Appl Environ Microbiol       Date:  1983-08       Impact factor: 4.792

7.  Adaptive response and enhancement of N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis by chloramphenicol in Streptomyces fradiae.

Authors:  R H Baltz; J Stonesifer
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

8.  Incorporation of amino acid-derived carbon into tylactone by Streptomyces fradiae GS14.

Authors:  J E Dotzlaf; L S Metzger; M A Foglesong
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Genetic analysis of erythromycin production in Streptomyces erythreus.

Authors:  J M Weber; C K Wierman; C R Hutchinson
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

Review 10.  Enzymes of secondary metabolism and the biosynthesis of macrolide antibiotics.

Authors:  J Neuzil; Z Hostálek
Journal:  Folia Microbiol (Praha)       Date:  1986       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.